GlassScriptPhysician profile
Michael A Fabian
NPI 1134124753
$3,018.20
in general payments reported to CMS, 2019-2025
51 companies · $482 in 2025
The $482 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $131 · 2021: $426 · 2022: $337 · 2023: $542 · 2024: $734 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $243.23 | 2019-2025 | Stravix, Pico 14, Stravix Pl |
| Dilon Technologies, INC. | $193.47 | 2022-2024 | Hemoblast Bellows |
| Intuitive Surgical, INC. | $177.73 | 2024 | |
| Daiichi Sankyo INC. | $172.17 | 2021-2025 | Enhertu |
| Astrazeneca Pharmaceuticals LP | $171.20 | 2023-2025 | Enhertu, Imfinzi |
| Kerecis Limited | $131.75 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Tela Bio, INC. | $127.81 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $107.98 | 2019-2025 | Harmonic, Echelon; Endopath, Echelon Circular |
| Novartis Pharmaceuticals Corporation | $100.35 | 2019-2023 | |
| Lilly USA, LLC | $100.15 | 2021-2024 | Retevmo, Verzenio, Jaypirca |
| Covidien LP | $100.09 | 2019 | |
| Hologic Sales and Service, LLC | $98.64 | 2023-2024 | Trunode, Coolseal Generator |
| Davol INC. | $86.79 | 2020-2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $75.84 | 2019-2025 | Gore Enform Preperitoneal Biomaterial |
| Stability Biologics, LLC | $70.87 | 2021 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Fabian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.